MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
7,542
Unique beneficiaries
—
Total services
166,201
Distinct HCPCS
57
Medicare payment
$2.0M
Peer benchmark
Total Medicare services vs. 133 Rheumatology providers in MD — top quintile (cohort median 27,542).
PRESCRIBING · PART D · 2024
Total Rx claims
1,255
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
23
Brand share
28.7%
Top prescribed drugs
Alendronate Sodium234 claims
Methotrexate Sodium167 claims
Hydroxychloroquine Sulfate132 claims
Prednisone125 claims
Allopurinol88 claims
QUALITY · MIPS · 2024
Final MIPS score
85.7
Quality
93.4
Cost
59.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.45%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Emma Diiorio's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 85 | 189 |
| Ashley Beall Rheumatology · Rockville, MD | 60 | 96 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 24 | 61 |
| MONTGOMERY GENERAL HOSPITAL, INC. | 12 | 26 |
| Tara Cameron Physical Therapist in Private Practice · Wheaton, MD | 12 | 85 |
| Joseph Ball Pulmonary Disease · Gaithersburg, MD | 12 | 27 |
| Quest Diagnostics Nichols Institute, Inc. Clinical Laboratory · Chantilly, VA | 12 | 19 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE